scorecardresearch
Add as a preferred source on Google
Sunday, September 28, 2025
TopicCDSCO

Topic: CDSCO

US lawsuit settlement puts spotlight back on ranitidine. India still undecided on ‘cancer-risk’ drug

Ranitidine still sold as popular heartburn medicine in India despite being banned or suspended in US, Europe & Australia. It was dropped from essential medicines list last year.

Reporting faulty manufacture to annual audits: How govt wants drugmakers to improve quality

Nearly 80 percent of small and medium drug manufacturing units in India do not follow good manufacturing practices (GMP) requirements, according to government estimates.

Indian firms linked to cough syrup deaths had received warnings, found quality shortfalls

The medicines either did not contain the claimed volume of ingredients or failed to dissolve quickly enough for absorption by the body, according to the records.

Kerala doctors & researchers plan India’s 1st private drug quality assessment drive

Project follows outcry over NMC rule, now on hold, asking medical practitioners to prescribe generics or face penalty. Dr Cyriac Abby Philips or ‘@TheLiverDoc’ part of project.

After small firms, India’s drug regulator puts big companies supplying to US, EU under scanner

Exercise by Central Drugs Standard Control Organisation began as crackdown on small & medium drugmakers, but is being expanded to include major firms after complaints over quality control.

India’s drug regulator approves study on mixing of Covaxin, Covishield vaccine doses

The Central Drugs Standard Control Organisation on 29 July had recommended granting permission to the study that will be conducted by the Christian Medical College in Vellore.

CDSCO expert panel recommends nod to conduct trial of mixing Covaxin, Covishield doses

The study, conducted by Christian Medical College in Vellore, aims to assess whether a person can be given two different Covid vaccine shots to complete the inoculation course.

‘No uniform test for cancer-causing substances in J&J baby products’ — drug regulator summoned

Child rights body issues summons over lack of standard testing methods to screen for presence of formaldehyde and asbestos in Johnson & Johnson’s baby shampoo and talcum powder.

Antidepressant Escitalopram ‘linked to suicidal thoughts’, must carry strongest warning — govt

Citing FDA warning, India's drug regulator starts examining warnings, prescribing information and package inserts given by Indian drugmakers manufacturing Escitalopram.

Strict follow-up, informed consent from recipients — conditions set for cleared Covid vaccines

India has given conditional emergency-use licence to two Covid vaccines — the Oxford-AstraZeneca candidate Covishield, and Bharat Biotech’s Covaxin.

On Camera

We can’t just blame Muslims and Englishmen for shattered Hindu unity: RSS chief Deoras

In May 1974, RSS chief Madhukar Dattatraya Deoras spoke at a lecture series in Pune about caste-based discrimination and social equality within the Hindu fold.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

With MiG-21’s exit, India’s squadron strength hits 6-decade low. What are IAF’s plans for the Tejas

While the IAF remains committed to the Tejas programme and has placed orders for 180 Tejas Mk1A, the force is eagerly waiting for the Tejas Mk 2 version.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.